Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria

NCT01038895 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Type 2 Diabetes

Interventions

DRUG: Ramipril
DRUG: Experimental

Sponsor

University of Pavia